Picture of Nuformix logo

NFX Nuformix Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Nuformix, fiscal year end - September 30th, GBP millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
September 30th
Period Length:12 M12 M12 M12 M18 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.66-0.756-1.25-1.11-0.859
Depreciation
Non-Cash Items0.834-0.0510.078-0.141-0.072
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.4750.0080.237-0.1330.28
Change in Accounts Receivable
Change in Accounts Payable
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-0.299-0.718-0.845-1.35-0.596
Capital Expenditures-0.027-0.043-0.0010
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items000.04400.05
Sale of Business
Sale of Fixed Assets
Cash from Investing Activities-0.027-0.0430.04400.05
Financing Cash Flow Items-0.007-0.01-0.0030
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.0071.31.930.140.285
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.3340.541.13-1.21-0.262